1. Date of Change: April 15, 2026 2. Functional Committee Name: Audit Committee, Compensation Committee 3. Former Committee Member Name: Shi Bo-yuan 4. Brief Biography of Former Incumbent: Shi Bo-yuan: Head of Strategic Investment Department, Da Jiang Biological Technology Co., Ltd. 5. New Committee Member Name: Not applicable 6. Brief Biography of New Appointee: Not applicable 7. Reason for Change (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'New Appointment'): Resignation 8. Reason for Change: Statement from the committee: Due to the dismissal ruling made by the commercial court in case number 115 Commercial Interim No. 3, the committee believes it is no longer possible to effectively exercise the supervisory responsibilities of an independent director and audit committee member to safeguard the best interests of the company and all shareholders. Therefore, it has been decided to resign from the position of independent director of the company, effective April 15, 2026, simultaneously resigning from the positions of audit committee member and compensation committee member. This statement is made on this date. 9. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): November 22, 2024 ~ November 21, 2027 10. Effective Date of New Appointment: Not applicable 11. Other Matters to be Noted: None.
FACT BOX
- Source: PR Times
- Category: 人事